1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment | Patent Publication Number 20100297240
US 20100297240 A1Patent NumberUS 08722684 B2
Application Number12301061
Filled DateJun 15, 2007
Priority DateJun 16, 2006
Publication DateNov 25, 2010
Original AssigneeH. Lundbeck As
Current AssigneeH. Lundbeck As
Inventor/ApplicantsMichael J. Mealy
Michael Harold Rock
Heidi Lopez de Diego
Arne Mork
Benny Bang-Andersen
Rene Holm
Morten Jorgensen
Tine Bryan Stensbol
Heidi Lopez De Diego
Andre Faldt
Lone Munch Ringgaard
Jorgen Brodersen
Nicholas Moore
Michael Harold Rock
Heidi Lopez de Diego
Arne Mork
Benny Bang-Andersen
Rene Holm
Morten Jorgensen
Tine Bryan Stensbol
Heidi Lopez De Diego
Andre Faldt
Lone Munch Ringgaard
Jorgen Brodersen
Nicholas Moore
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.